Publications on Thailand
Pacific Bridge Medical has published numerous articles in leading trade journals pertaining to the medical market in Thailand. Our consultants and researchers are constantly identifying pertinent new medical device and pharmaceutical regulations, trends, and other information. The published articles, reports, and webcasts below are free or for purchase.
ASEAN Medical Device Regulatory Integration
Published in MPO
Navigating global regulatory markets can be a challenge, particularly when multiple countries in a region differ in their rules. Playing by a common set of rules for medtech regulation is about to get a little easier in Southeast Asia, as a group of countries prepares to unveil a more unified approach to oversight.
ASEAN Medical Device Harmonization Trends
Published in Pacific Bridge Medical Webcast
$400 | Buy Webcast
Regulatory harmonization, post-marketing surveillance schemes, and a Common Submission Dossier Template are just some of the new plans the Association of Southeast Asian Nations (ASEAN) has been working on recently. Are you aware of the newest regulations and trends in Southeast Asia? Though some of these nations' medical device regulations have been minimal or nonexistant in the past, increased regulation and rapid change are now underway.
Thailand Pharmaceutical and Medical Device Markets
Published by Pacific Bridge Medical
The Thai Food and Drug Administration (FDA), under the Ministry of Public Health (MOPH), is responsible for protecting the health of consumers by ensuring the safety, quality and efficacy of health products, including food, pharmaceuticals, medical devices and cosmetics, in Thailand. The FDA has five main areas of focus: (1) pre-marketing, (2) post-marketing, (3) product surveillance, (4) product education for the consumer and (5) cooperation with other health-related agencies. Presently, the FDA has close to 500 staff members who run the agency, including pharmacists, nutritionists, lawyers and other health professionals.
Overview of Asia, Healthcare Markets and Regulatory Issues in the Region
Presentation at Regulatory Affairs Professional Society (RAPS) Conference
Despite sluggish economies in some countries, Asia still represents future growth opportunities in healthcare products. Over the next 20 years, Asian healthcare markets are expected to grow at a rate two and a half times that of the West. A rising standard of living throughout the region means patients will have the resources to acquire modern medical devices and pharmaceuticals. As the globalization of healthcare continues, regulatory practices for pharmaceuticals and medical devices will be further harmonized. This report examines emerging regulatory trends and issues in China, Japan, Hong Kong, India, Indonesia, Malaysia, the Philippines, Singapore, South Korea, Taiwan and Thailand.
New Regulatory Trends in Thailand’s Pharmaceutical Market
Published by Pacific Bridge Medical
Despite the harsh effects of the Asian financial crisis, pharmaceutical markets in Asia still have a bright future. Thailand’s pharmaceutical market suffered drops in 1997 and 1998 but renewed consumer demand and increased incomes are helping rebound the Thai pharmaceutical market growth rate. The Food and Drug Administration (FDA), under the Ministry of Public Health (MOPH), is working to revise the regulatory situation for pharmaceuticals entering the Thai market. The MOPH is making an effort to revise its drug classification system, regulatory procedures, pricing and competition controls, marketing regulations, and intellectual property protections in order to liberalize the market and minimize corruption. This article discusses the reform trends in Thailand’s pharmaceutical market that will most likely ease the obstacles that foreign companies face in this dynamic drug market.
Thailand Will Enter the 21st Century with a Growing Device Market
Published in Medical Device & Diagnostic Industry
As aging populations continue to expand in Asian nations, governments are keen to revise their healthcare systems to accommodate this growth. While Thailand’s medical device market expands, opportunities for U.S. and foreign medical device manufacturers will continue to flourish. Like most developed nations, Thailand’s citizens are afflicted with cancer, strokes, cardiovascular diseases and traffic accidents. These illnesses and hazards mean that more advanced medical device technology will be in great demand over the next several years. This article highlights Thailand’s healthcare system and spending, as well as the marketing of medical products in Thailand and new medical device regulations. Recent success stories by foreign companies in Thailand, including BioWhittaker, Inc., are also discussed.
Blog/RSS